Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Liabilities and Shareholders Equity (2019 - 2025)

Historic Liabilities and Shareholders Equity for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $138.3 million.

  • Pulmonx's Liabilities and Shareholders Equity fell 1739.54% to $138.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $599.1 million, marking a year-over-year decrease of 1221.28%. This contributed to the annual value of $162.8 million for FY2024, which is 839.85% down from last year.
  • Latest data reveals that Pulmonx reported Liabilities and Shareholders Equity of $138.3 million as of Q3 2025, which was down 1739.54% from $147.2 million recorded in Q2 2025.
  • Pulmonx's 5-year Liabilities and Shareholders Equity high stood at $255.3 million for Q1 2021, and its period low was $138.3 million during Q3 2025.
  • Over the past 5 years, Pulmonx's median Liabilities and Shareholders Equity value was $193.1 million (recorded in 2023), while the average stood at $193.6 million.
  • Per our database at Business Quant, Pulmonx's Liabilities and Shareholders Equity skyrocketed by 24644.04% in 2021 and then crashed by 1822.81% in 2024.
  • Over the past 5 years, Pulmonx's Liabilities and Shareholders Equity (Quarter) stood at $235.2 million in 2021, then fell by 17.65% to $193.7 million in 2022, then decreased by 8.21% to $177.8 million in 2023, then decreased by 8.4% to $162.8 million in 2024, then dropped by 15.09% to $138.3 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $138.3 million for Q3 2025, versus $147.2 million for Q2 2025 and $150.7 million for Q1 2025.